RxDoctor Payments Data

Jacqueline Fredrick

Optometrist · Haymarket, VANPI 1407824394

Payments from drug & device makers

$2,447in general payments, 2019–2025

Across 77 payments — averaging $31.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bausch & Lomb, A Division Of Bausch Health US, LLC$506
  • Bausch & Lomb Americas Inc.$333
  • Sun Pharmaceutical Industries Inc.$323
  • Alcon$199
  • Johnson & Johnson Surgical Vision, Inc.$135
  • Shire North American Group Inc$122
  • plus $829 from 14 others

What the payments were for

  • Food & beverage$2,447100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,447 in reported general payments places this provider in the 75th percentile of 1,230 optometrist providers in Virginia.

See all optometrist providers in Virginia

Most prescribed under Part D

DrugClaimsCost to plans & patients
RestasisCyclosporine14$22,489
Timolol Maleate24$5,397
Latanoprost82$1,445
Loteprednol Etabonate11$1,434
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha20$250
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat17$139
ErythromycinErythromycin Base16$138

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieRestasis$76$22,48914 claims
Bausch & Lomb, A Division Of Bausch Health US, LLCLoteprednol Etabonate$506$1,43411 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,230 optometrist providers in Virginia.

Other optometrist in Haymarket

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →